IBT
HARP

International Biotechnology Trust’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

International Biotechnology Trust’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,145
Closed -$2.77M – 82
2022
Q1 		$2.77M Sell
15,145
-6,355
-30% -$329K 0.62% 38
2021
Q4 		$1.62M Hold
21,500
– – 0.36% 48
2021
Q3 		$1.7M Buy
+21,500
New +$2.16M 0.41% 42

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

International Biotechnology Trust's HARP Position: Q2 2022 in Review

International Biotechnology Trust sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 15,145 shares — an estimated $2.77M sold.

International Biotechnology Trust first reported a position in HARP in Q3 2021 and held it in 3 quarters. The position peaked at $2.77M in Q1 2022. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

  • International Biotechnology Trust reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 15,145 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $2.77M.
  • International Biotechnology Trust first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • International Biotechnology Trust's Harpoon Therapeutics, Inc. Common Stock position peaked at $2.77M in Q1 2022.
  • 63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on International Biotechnology Trust's 13F filing for Q2 2022, filed 16 Aug 2022.